+91 6376341881
SoMex Research & Health Organization
Clinical Research Organization

Latest News



Emerging evidence of Nimotuzumab (BioMab EGFR) in Esophageal Cancers


Safety and efficacy of anti EGF receptor humanized monoclonal antibody Nimotuzumab in unresectable esophoageal tumors in combination with chemo-radiotherapy: Phase II clinical trial final results one quite impresive.




Other Latest News


SoMex Research & Health Organization

Get in Touch

+91-141-2504996
somexresearch@gmail.com
www.somexresearch.com

About

Services